Patents Examined by Theodore J. Stigell
  • Patent number: 11511097
    Abstract: Provided herein is a system including, in some embodiments, a streamlined port and a port tunneler. The port includes a septum and a stabilizing element. The septum is disposed over a cavity in a body of the port, and the septum is configured to accept a needle therethrough. The stabilizing element is configured to stabilize the port in vivo and maintain needle access to the septum. The port tunneler includes an adapter and a release mechanism. The adapter is in a distal end portion of the port tunneler, and the adapter is configured to securely hold the port while subcutaneously tunneling the port from an incision site to an implantation site for the port. The release mechanism is configured to release the port from the adapter at the implantation site for the port.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: November 29, 2022
    Assignee: C. R. Bard, Inc.
    Inventors: Jeremy B. Cox, James D. Meler, II, Michael Randall, Chad Van Liere
  • Patent number: 11504515
    Abstract: Described herein is an implantable access port device with a catheter compartment which permits lengthening or shortening the catheter in response to changes in tension of the distal catheter. Implantable access port devices are used extensively in the medical field to facilitate the performance of recurrent therapeutic tasks such as repeated drug delivery, drainage, blood sampling, transfusions, or total parental nutrition. In current access port systems, the catheter is rigidly attached to the access port via a connection ring. As such, the system does not provide any flexibility or ability for catheter length adjustments, which can lead to long-term complications such as dislodgement of catheters, migration of catheters, port separation with extravasation, suture disruption, and mechanical failure of the access port system. These catheter-related complications carry serious risks for the patients.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: November 22, 2022
    Assignee: IMOTIK BIOSOLUTIONS LLC
    Inventors: Pericles Calias, Michel Morency
  • Patent number: 11504478
    Abstract: The present specification relates to a subassembly for a drug delivery device, the subassembly comprising: a housing adapted to contain a drug container with a needle, a cap, and a spacer, wherein the housing has an inner surface forming a cavity configured to retain the drug container, wherein the cap is configured to be releasably connected to the housing, and wherein the spacer is arranged between the cap and the housing.
    Type: Grant
    Filed: October 29, 2018
    Date of Patent: November 22, 2022
    Assignee: Sanofi
    Inventor: Thomas Mark Kemp
  • Patent number: 11497898
    Abstract: Catheters with weeping balloons can be used for various medical purposes. For example, in some embodiments provided herein weeping balloons are used for catheter visualization devices. In some embodiments, weeping balloons are used to deliver therapeutic agents. Weeping balloons can include openings of a selected size and shape through which a fluid gradually flows or “weeps.” The design of the openings can affect performance characteristics such as, but not limited to, fluid flow rate, tear resistance, and mitigation of counter-flow.
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: November 15, 2022
    Assignees: Boston Scientific Scimed, Inc., Mayo Foundation For Medical Education And Research
    Inventors: James M. Anderson, David Raab, Adam David Grovender, Roger W. McGowan
  • Patent number: 11497682
    Abstract: A container for collecting, transporting, storing, delivering and dispensing fluid. The container has a hollow tube with an outer circumference diameter and is configured to receive a plunger. A collection adaptor and a dispensing adaptor provide interchangeable coupling of a variable volume container such as a syringe with a collection device such as a breast pump and a dispensing device such as a nipple. The container also has a circumferential seal assembly secured at one end of the hollow tube. The seal assembly outer diameter is substantially similar to the hollow tube outer diameter.
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: November 15, 2022
    Assignee: Avent, Inc.
    Inventors: Aaron N. Ingram, Benjamin Martin Davis, Anthony C. Lair, Mark Martin Costello, Tony Doherty
  • Patent number: 11497858
    Abstract: A needle shield remover for a medicament delivery device is presented that has a metal tubular body, a proximal part, a distal part, and a substantially circular cross-section, where the tubular body is arranged with a slot extending from a distal end of the body, at least half the length of the body, towards a proximal end, such that at least the distal part of the body may flex radially outwards to exert a radially inwardly directed clamping force on a needle shield accommodated by the body.
    Type: Grant
    Filed: September 10, 2018
    Date of Patent: November 15, 2022
    Assignee: SHL MEDICAL AG
    Inventors: Anders Holmqvist, Pär Leander
  • Patent number: 11497856
    Abstract: Systems and methods for monitoring an operational state and/or a fill status of a drug container of a drug delivery device are provided. The drug container can hold a liquid drug. A plunger can be positioned within the drug container. A drive system can advance the plunger to expel the liquid drug from the container. A monitoring system can detect a movement and/or a position of the plunger and/or any component coupled to the plunger. The detection can enable determination of an amount of liquid drug that has been expelled and/or an amount of liquid drug remaining in the drug container. Dosing rates, flow rates, and dosage completion can also be determined.
    Type: Grant
    Filed: August 7, 2019
    Date of Patent: November 15, 2022
    Assignee: Insulet Corporation
    Inventors: David Nazzaro, Ian McLaughlin, Daniel Allis, Simon Kozin, Maureen McCaffrey
  • Patent number: 11497845
    Abstract: A trans anal irrigation device that can be used on a bed. The device includes a rectal catheter connected to an irrigation fluid supply. A waste collection bag is also connected to the catheter. The catheter may be insertable in a seat attached to a fluid supply line. A valve in one of the catheter or seat selectably allows or prevents fluid communication between the catheter and a waste collection bag. The catheter may include an inflationless cuff made of a flexible material that permits it to be inserted in the rectum to prevent leakage around the exterior of the catheter.
    Type: Grant
    Filed: May 26, 2020
    Date of Patent: November 15, 2022
    Assignee: Hollister Incorporated
    Inventors: Adam J. Foley, Stephen Collum, Denise Gamblin, William K. Arnold, Ruchi Seth, Jerome A. Henry, Malford E. Cullum, George J. Cisko
  • Patent number: 11491277
    Abstract: The syringe includes a hollow body with at least one free-floating piston and a plunger within the body, with the piston between the plunger and a proximal end of the body. A manifold is provided lateral to the body. The manifold leads to an input/output tip. The manifold includes a front port located between the piston and the proximal end of the body and a rear port spaced from the proximal end of the body. The manifold includes at least one flow path leading from the input/output tip to at least one of the front port and/or the rear port. A first fluid fills a rear chamber distal to the piston and then the manifold is adjusted to fill second fluid into a front chamber proximal of the piston, and then the manifold is adjusted to allow sequential delivery of the second fluid and the first fluid.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: November 8, 2022
    Assignee: MonuMedical, LLC
    Inventor: David R. Duncan
  • Patent number: 11491318
    Abstract: A multi-use disposable set (MUDS) has at least one syringe having a proximal end and a distal end spaced apart from the proximal end along a longitudinal axis. The MUDS further has a plunger reciprocally movable within a syringe interior between the proximal end and the distal end. A manifold is in fluid communication with the distal end of the at least one syringe. At least one valve is in fluid communication with the syringe interior. The at least one valve is operable between a filling position for filling the syringe interior with fluid and a delivery position for delivering the fluid from the syringe interior. At least one connection port is in fluid communication with the manifold and the syringe interior when the at least one valve is in the delivery position. A multi-fluid delivery system having the medical connector and MUDS is also provided. Various features of the MUDS system are also described.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: November 8, 2022
    Assignee: BAYER HEALTHCARE LLC
    Inventors: John Haury, Michael Swantner, Richard Sokolov, Benjamin James Cullen, Alison Ruth Von Moger, Ernesto Hueso Monis, Kamman Law, Mark Silivio Profaca, Patrick Spence, Michael Spohn, Justin Angert, Brian Cain
  • Patent number: 11491276
    Abstract: Release of a neurological drug in a targeted region of a subject's brain by a drug delivery system (DDS) is intentionally caused by the subject watching or interacting with an audio/video-based task on an electronic display. The DDS is calibrated to release the neurological drug based on a particular pH, lactate level, blood flow, temperature, magnetic field, specific molecules released by brain cells, or other physiological factors within the target region. The interactive task produces the physiological factors in the brain in specific areas of pathology for which the drug is prescribed, and limits drug delivery at areas unaffected by illness where it could disrupt normal function, causing problematic side effects and preventing dose levels optimal for target impact. Feedback from the interactive task and associated cognitive probes also can adapt the interactive task or suggest new pharmacologic agents as the degree or primary focus of brain pathology changes during the course of treatment.
    Type: Grant
    Filed: March 4, 2022
    Date of Patent: November 8, 2022
    Inventor: Bruce E. Wexler
  • Patent number: 11484594
    Abstract: Various embodiments of bulking or cushioning agents or material and related medical devices and methods are disclosed. For example, a method of performing a medical procedure in a tract of a body may include injecting a material in a liquid phase proximate a target site between a first tissue layer and a second tissue layer, allowing the material to transition from the liquid phase to the gel phase in response to a raise in temperature of the material to approximately at or above the predetermined temperature, and performing a surgical procedure on the target site. The material may have the liquid phase at temperatures below a predetermined temperature and a gel phase at temperature approximately at or above the predetermined temperature.
    Type: Grant
    Filed: December 22, 2021
    Date of Patent: November 1, 2022
    Assignee: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Paul Scopton, Samuel Zhong, Yem Chin
  • Patent number: 11484644
    Abstract: A user-initiated fluid pathway connection includes: a connection hub, a piercing member, a sterile sleeve, and a drug container having a cap, a pierceable seal, a barrel, and a plunger seal, wherein the piercing member is initially retained within the sterile sleeve between the connection hub and the pierceable seal of the drug container. The connection hub may include an internal aperture within the connection hub which functions as a flow restrictor and wherein a piercing member is connected to one end of the internal aperture and a fluid conduit is connected to another end of the internal aperture. A drug delivery pump with integrated sterility maintenance features includes a housing, upon which an activation mechanism, an insertion mechanism, a fluid pathway connection as described above, a power and control system, and a drive mechanism connected to a drug container are mounted. Methods of assembly and operation are also provided.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: November 1, 2022
    Inventors: Sean M. O'Connor, Ian B. Hanson, Paul F. Bente, IV, Rajan Ramaswamy, Daniel S. Codd, Scott W. Beaver, Kevin Bokelman, John C. Love
  • Patent number: 11484649
    Abstract: A valve assembly for a drug delivery device includes a valve housing having a first side and a second side positioned opposite from the first side, a cannula having a first end and a second end positioned opposite the first end, a pierce plate having a body and a piercing member extending from the body, with the body defining a coiled elongate member, and a valve boot connected to the valve housing and defining an interior space. The valve boot is configured to move from a pre-use position where the first end of the cannula and the piercing member of the pierce plate are received within the interior space to a use position where the piercing member of the pierce plate and the first end of the cannula extend outside of the valve boot and the interior space.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: November 1, 2022
    Assignee: Becton, Dickinson and Company
    Inventors: Margarita Falkovich, Venkateswaran Santhanam, Peter Skutnik
  • Patent number: 11484663
    Abstract: The disclosure relates to a drug delivery device including: a housing configured to contain a drug container with a needle, a needle shroud that is telescopically connected to the housing, and a cap that is configured to be releasably connected to the housing before use of the device. At least one of the cap and the needle shroud is adapted to unreleasably lock the cap onto the housing after reapplying the cap onto the housing after the drug delivery device is used.
    Type: Grant
    Filed: November 1, 2018
    Date of Patent: November 1, 2022
    Assignee: Sanofi
    Inventors: Marc Schader, William Timmis, Thomas Mark Kemp, Jim Bradford
  • Patent number: 11478588
    Abstract: A needle guard grip device may include a body extending from a first end to a second end along a central longitudinal axis of the body. The body may include a plurality of ribs extending perpendicularly to the central longitudinal axis. The plurality of ribs may include a first set of longitudinally spaced ribs disposed on a first side of the central longitudinal axis, and a second set of longitudinally spaced ribs disposed on a second side of the central longitudinal axis that is opposite of the first side. Moving along the central longitudinal axis, ribs of the first set of longitudinally spaced ribs may alternate with ribs of the second set of longitudinally spaced ribs.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: October 25, 2022
    Assignee: REGENERON PHARMACEUTICALS, INC.
    Inventors: Bryan Grygus, Richard Jeff Gildersleeve, Shaina Varghese
  • Patent number: 11471588
    Abstract: A method for performing a medical procedure requiring effective, reliable and foolproof delivery of controlled amounts of a medical grade gas to a patient includes providing a compressed gas cylinder having a weight with medical grade gas sealed therein of at least twelve grams and not greater than fifty grams. The method also includes connecting the compressed gas cylinder to an integrated compressed gas unit including a regulator valve assembly positioned between an outlet port and an inlet port, wherein the regulator valve assembly includes a press button actuator and regulator adjustment dial. A flow control system is secured to the compressed gas unit and the medical grade gas is delivered in precisely controlled amounts by actuating the compressed gas unit and operating the flow control system to deliver the medical grade gas to vasculature of the patient.
    Type: Grant
    Filed: November 5, 2018
    Date of Patent: October 18, 2022
    Inventors: Frank Levy, Kimberley Levy
  • Patent number: 11464892
    Abstract: A method of delivering a therapeutic substance for treatment to a region of the body through vascular isolation and manipulation of fluid flux into and from the region of the body including the steps of: restricting vascular inflow to the region of the body; washing out oncotically active plasma proteins from the region of the body by increasing the outward oncotic pressure gradient from the region of the body; inducing ischemia in the region of the body; controlling the pressure and fluid flow of the main blood vessels to and from the region of the body; providing the therapeutic substance to the region of the body when the fluid flow to the region of the body is controlled.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: October 11, 2022
    Assignee: All Vascular Pty Limited
    Inventors: Rodney James Lane, Matthew James Huckson, Chris Kyung, David Lane, Nyan Khin, Scott Murphy
  • Patent number: 11452821
    Abstract: A device for removing a protective shield such as a needle shield is disclosed. The device includes a cup shaped body with a sidewall, a distal bottom wall and a proximal opening. The protective shield is insertable into the cup shaped body through its proximal opening. Fingers are disposed opposite each other in openings in the sidewall. The fingers are flexibly coupled with the sidewall at a proximal end of the finger and can be resiliently biased inwardly to engage the protective shield. Each finger includes at least one projection for engaging the protective shield. The fingers may also include a distal engagement surface for engaging a lip on the protective shield.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: September 27, 2022
    Assignee: Eli Lilly and Company
    Inventors: Mark Lafever, Andrew Thomas Snow
  • Patent number: 11446434
    Abstract: An inserter assembly comprising a first unit including a skin contacting face which surrounds an opening and a second unit housed within the first unit. The second unit comprises an infusion set base disposed within the opening and having a bottom face which is substantially level with the skin contacting face and covered at least partially with adhesive and further comprising a spring biased insertion assembly. The second unit further comprising a cannula sub assembly carried by an insertion sharp of the insertion assembly. The spring biased insertion assembly and a cannula of the cannula sub assembly are driven into skin and the cannula sub assembly is coupled into the infusion set base by an insertion spring which is released from an energy storing state after the skin has been tugged upward beyond a certain distance by the adhesive as the inserter assembly is withdrawn from the body.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: September 20, 2022
    Assignee: DEKA Products Limited Partnership
    Inventors: Richard J. Lanigan, Joshua I. Ferris